Article
In vivo priming effects of interferon-beta ser on NK activity of peripheral blood mononuclear cells in cancer patients.
Therapeutic immunology - 1 Feb 1995
Fujimiya Y, Wagner R J, Groveman S, Sielaff K, Kohsaka T, Nakayama M
Abstract excerpt
Natural killer (NK) activity was assayed in fresh peripheral blood mononuclear cells (PBMs) from cancer patients receiving interferon (IFN)-beta ser. Patients received a single intravenous injection of IFN-beta ser (90 x 10(6) IU m-2) on alternate days for 2 weeks, followed by a higher dose (180...
Topics
- ADP-ribosyl Cyclase
- ADP-ribosyl Cyclase 1
- Antigens, CD
- Antigens, Differentiation
- CD56 Antigen
- Cytotoxicity, Immunologic
- Humans
- In Vitro Techniques
- Interferon Type I
- Interferon beta-1a
- Interferon beta-1b
- Interferon-beta
- Interferon-gamma
- Killer Cells, Natural
- Leukocytes, Mononuclear
- Membrane Glycoproteins
- N-Glycosyl Hydrolases
- Neoplasms